Prevention of alcohol withdrawal syndrome in surgical ICU: AAST releases consensus

Screening Tools

• The authors recommend that patients be screened within 6 to 24 hours ofdiscontinuation of alcohol consumption. Blood alcohol level (BAL) can serve asan initial screen; however, subjective scoring systems (The Alcohol UseDisorders Identification Test (AUDIT), The Prediction of Alcohol WithdrawalSeverity Scale (PAWSS)) have higher sensitivity and specificity for the predictionof AWS.
• In theabsence of clear designation of which other services are necessary forscreening and intervention for patients at risk for alcohol withdrawal,multiple services as available in individual institutions can be considered forassistance in managing AWS. Social Work, Addiction Medicine, Psychiatry,Psychiatry Nursing, or Psychology can help standardize the implementation ofscreening and intervention.

Empiric Prophylaxis

• Empiricprophylaxis for alcohol withdrawal is beneficial and has decreasedcomplications from alcohol withdrawal for patients at risk for severe orcomplicated AWS.
• The current bestpractice is for critically ill patients admitted to a surgical ICU and deemedhigh risk for AWS based on objective criteria to receive empiric alcohol withdrawalprophylaxis.
• Inpatients at high risk for complicated alcohol withdrawal but do not otherwisemeet the criteria for SICU admission may be admitted to a monitored setting (SICUvs surgical stepdown) with telemetry and pulse oximetry capabilities to initiate alcohol withdrawal prophylaxis therapy.

Surveillance Methods

• The use of the modified Minnesota Detoxification Scale (mMINDS) is recommended forICU patients at risk for AWS.

Medications

• The authors recommendbenzodiazepines for the treatment of major symptoms of AWS and prophylaxis against the worsening of mild AWS. Recommended agents are diazepam,lorazepam, and chlordiazepoxide, to be used in a standardized administrationprotocol.
• Phenobarbital is a safe and effective pharmacologic agentfor use in the prevention and treatment of AWS. Due to the pharmacokinetics andlong half-life of phenobarbital, a fixed-dose approach is recommended.
• Clonidineand gabapentin arerecommended; intravenous ethanol and non-phenobarbital antiepilepticsare not currently recommended as they are not equivalent to benzodiazepines.Dexmedetomidine and propofol are recommended as benzodiazepine adjuncts.

Supplementation

• Micronutrientdeficiencies are common in those with chronic or severe AUD. Thiamine (vitaminB1), magnesium, phosphorus, and folic acid (vitamin B9) should be given assupplements during the acute period of critical care, even in the absence ofsymptoms of AWS.

Reference:

Seshadri A, Appelbaum R, Carmichael SP 2nd, Farrell MS, Filiberto DM, Jawa R, Kodadek L, Mandell S, Miles MVP, Paul J, Robinson B, Michetti CP. Prevention of alcohol withdrawal syndrome in the surgical ICU: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document. Trauma Surg Acute Care Open. 2022 Nov 21;7(1):e001010. doi: 10.1136/tsaco-2022-001010. PMID: 36425749; PMCID: PMC9680182.